Skip to Main content Skip to Navigation
Journal articles

Major pitfalls of protein kinase inhibitors prescription: a review of their clinical pharmacology for daily use

Abstract : Protein kinase inhibitors (PKI) are a growing class of anticancer agents. They are prescribed with flat doses, and their oral administration is associated with interindividual variability in exposure. Patients can be over- or underexposed, due to numerous factors. We reviewed key pharmacokinetic concepts and mechanisms by which PKIs prescription could be altered. Challenging situations that could lead to increased toxicity or to therapeutic failure are described and recommendation for clinicians are proposed. Finally, the interest of therapeutic drug monitoring and indications for its use in daily practice is discussed.
Complete list of metadata

Cited literature [160 references]  Display  Hide  Download

https://hal.sorbonne-universite.fr/hal-02289357
Contributor : Hal Sorbonne Université Gestionnaire <>
Submitted on : Monday, September 16, 2019 - 3:48:24 PM
Last modification on : Thursday, September 2, 2021 - 9:08:50 AM
Long-term archiving on: : Saturday, February 8, 2020 - 7:25:24 PM

File

Gougis et al. - 2019 - Major p...
Files produced by the author(s)

Identifiers

Citation

Paul Gougis, Lola-Jade Palmieri, Christian Funck-Brentano, Angelo Paci, Ronan Flippot, et al.. Major pitfalls of protein kinase inhibitors prescription: a review of their clinical pharmacology for daily use. Critical Reviews in Oncology/Hematology, Elsevier, 2019, 141, pp.112-124. ⟨10.1016/j.critrevonc.2019.06.006⟩. ⟨hal-02289357⟩

Share

Metrics

Record views

457

Files downloads

1171